
According to a court filing on Thursday, Canada’s Department of Justice has determined that Microsoft’s acquisition of Activision Blizzard, the creator of “Call of Duty,” could potentially result in reduced competition in certain areas of the gaming industry.
In a letter dated Wednesday, the department informed Microsoft’s US lawyers that it had conveyed to the lawyers of Microsoft and Activision in Canada that the deal would probably result in decreased competition in the areas of gaming consoles, multigame subscription services, and cloud gaming.
Read more: Sony Calls UK’s Reversed Stance On Microsoft Activision Deal ‘Surprising & Irrational’
On Thursday, a letter was submitted to a U.S. federal court regarding a proposed transaction. The U.S. Federal Trade Commission is seeking a temporary halt to the transaction in order for an FTC judge to evaluate it. Closing arguments are scheduled for later on Thursday.
Microsoft has requested a decision in the court battle before the July 18 deadline for the deal. A ruling may be made as soon as next week.
Microsoft is collaborating with antitrust enforcers to address concerns, as stated in their official statement. “We received notice from the Canada Competition Bureau that it would continue to monitor our acquisition of Activision Blizzard after the formal waiting period preventing the deal to close expired,” a Microsoft spokesperson said.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas